Production of drug metabolites is one area where enzymatic conversion has significant advantages over synthetic chemistry. These high value products are complex to synthesize, but are increasingly important in drug safety testing. The vast majority of drugs are metabolized by cytochromes P450 (P450s), with oxidative transformations usually being highly regio- and stereo-selective. The PPIs (proton pump inhibitors) are drugs that are extensively metabolized by human P450s, producing diverse metabolites dependent on the specific substrate. In the present paper we show that single mutations (A82F and F87V) in the biotechnologically important Bacillus megaterium P450 BM3 enzyme cause major alterations in its substrate selectivity such that a set of PPI molecules become good substrates in these point mutants and in the F87V/A82F double mutant. The substrate specificity switch is analysed by drug binding, enzyme kinetics and organic product analysis to confirm new activities, and X-ray crystallography provides a structural basis for the binding of esomeprazole to the F87V/A82F enzyme. These studies confirm that such ‘gatekeeper’ mutations in P450 BM3 produce major perturbations to its conformation and substrate selectivity, enabling novel P450 BM3 reactions typical of those performed by human P450s. Efficient transformation of several PPI drugs to human-like products by BM3 variants provides new routes to production of these metabolites.
Skip Nav Destination
Article navigation
June 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
May 13 2014
Human P450-like oxidation of diverse proton pump inhibitor drugs by ‘gatekeeper’ mutants of flavocytochrome P450 BM3
Christopher F. Butler;
Christopher F. Butler
*Manchester Institute of Biotechnology, Faculty of Life Sciences, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.
Search for other works by this author on:
Caroline Peet;
Caroline Peet
†Cypex Ltd, 6 Tom McDonald Avenue, Dundee DD2 1NH, U.K.
Search for other works by this author on:
Kirsty J. McLean;
Kirsty J. McLean
*Manchester Institute of Biotechnology, Faculty of Life Sciences, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.
Search for other works by this author on:
Michael T. Baynham;
Michael T. Baynham
‡Agilent Technologies UK Ltd, Lakeside, Cheadle Royal Business Park, Stockport, Cheshire SK8 3GR, U.K.
Search for other works by this author on:
Richard T. Blankley;
Richard T. Blankley
‡Agilent Technologies UK Ltd, Lakeside, Cheadle Royal Business Park, Stockport, Cheshire SK8 3GR, U.K.
Search for other works by this author on:
Karl Fisher;
Karl Fisher
*Manchester Institute of Biotechnology, Faculty of Life Sciences, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.
Search for other works by this author on:
Stephen E. J. Rigby;
Stephen E. J. Rigby
*Manchester Institute of Biotechnology, Faculty of Life Sciences, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.
Search for other works by this author on:
David Leys;
David Leys
*Manchester Institute of Biotechnology, Faculty of Life Sciences, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.
Search for other works by this author on:
Michael W. Voice;
Michael W. Voice
†Cypex Ltd, 6 Tom McDonald Avenue, Dundee DD2 1NH, U.K.
Search for other works by this author on:
Andrew W. Munro
Andrew W. Munro
1
*Manchester Institute of Biotechnology, Faculty of Life Sciences, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.
1To whom correspondence should be addressed (email Andrew.Munro@Manchester.ac.uk).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 07 2014
Revision Received:
March 03 2014
Accepted:
March 04 2014
Accepted Manuscript online:
March 04 2014
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2014 Biochemical Society
2014
Biochem J (2014) 460 (2): 247–259.
Article history
Received:
January 07 2014
Revision Received:
March 03 2014
Accepted:
March 04 2014
Accepted Manuscript online:
March 04 2014
Citation
Christopher F. Butler, Caroline Peet, Kirsty J. McLean, Michael T. Baynham, Richard T. Blankley, Karl Fisher, Stephen E. J. Rigby, David Leys, Michael W. Voice, Andrew W. Munro; Human P450-like oxidation of diverse proton pump inhibitor drugs by ‘gatekeeper’ mutants of flavocytochrome P450 BM3. Biochem J 1 June 2014; 460 (2): 247–259. doi: https://doi.org/10.1042/BJ20140030
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.